Thyroid Cancer & rhtsh: When and How?

Similar documents
Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer

I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER

A Review of Differentiated Thyroid Cancer

Adjuvant therapy for thyroid cancer

Clinical Policy Bulletin: Thyrogen (Thyrotropin Alfa)

Gerard M. Doherty, MD

Differentiated Thyroid Cancer: Initial Management

This was a multinational, multicenter study conducted at 14 sites in both the United States (US) and Europe (EU).

CLINICAL PHARMACOLOGY

Although adequate treatment of differentiated thyroid

THYROID CANCER IN CHILDREN

original article INTRODUCTION According to the American Thyroid Association ABSTRACT

CED-SOS Advice Report 5 EDUCATION AND INFORMATION 2012

Prior Authorization Review Panel MCO Policy Submission

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women

Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update

Persistent & Recurrent Differentiated Thyroid Cancer

Success rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer

Metastatic papillary thyroid cancers with malignant pleural effusion aggravated during thyroid hormone withdrawal for radioiodine therapy

Recombinant human TSH in radioiodine treatment of differentiated thyroid cancer

Diagnostic 131 I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status

저작권법에따른이용자의권리는위의내용에의하여영향을받지않습니다.

Approach to Thyroid Nodules

RESEARCH ARTICLE. Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer

TOTAL OR NEAR-TOTAL thyroidectomy is advocated in

Risk Adapted Follow-Up

Thyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA

Thyroid nodules. Most thyroid nodules are benign

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans

Thyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis

Anca M. Avram, M.D. Professor of Radiology

TOP 20 - THYROID ARTICLES

Correspondence should be addressed to Stan H. M. Van Uum;

Current Issues in Thyroid Cancer Surgery in 2017

Thyroid carcinoma. Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD D. Brdar, MD, nucl. med. spec.

Thyroid Update. Timothy C. Petersen, MD, ECNU

Imaging in Thyroid Cancer

Hayes Martin died on Christmas Day I was a fellow on the head and neck service at

Preoperative Evaluation

THE AIM OF postsurgical follow-up in patients with differentiated

Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide)

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

Integrating Guidelines, Experience, and Clinical Judgment in the Management of Thyroid Cancer AACE Annual Meeting May 5, 2016

Carcinoma tiroideo differenziato: gestione della persistenza biochimica di malattia

SCIENTIFIC DISCUSSION

Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer

Case-Based Discussion of Thyroid Cancer Therapy

5/3/2017. Ahn et al N Engl J Med 2014; 371

Disclosures. Learning objectives. Case 1A. Autoimmune Thyroid Disease: Medical and Surgical Issues. I have nothing to disclose.

Judicious use of recombinant TSH in the management of differentiated thyroid carcinoma

Inmaculada Prior-Sanchez*, Ana Barrera Martın*, Estefanıa Moreno Ortega, Juan A. Vallejo Casas and Marıa A. Galvez Moreno*

Iodine 131 thyroid Therapy. Sara G. Johnson, MBA, CNMT, NCT President SNMMI-TS VA Healthcare System San Diego

Key Topics in Thyroid Cancer Worldwide epidemic What Should the Endocrinologist and Surgeon do?

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

Thyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma.

rhtsh-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review

Behaviour of early thyroglobulin after total thyroidectomy for differentiated thyroid cancer. D. Pérez, M. Marulanda, A.

Thyroid Nodules. Hossein Gharib, MD, MACP, MACE

Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

14 Clinical Review Volume 2 No. 1, 2004

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

5/18/2013. Most thyroid nodules are benign. Thyroid nodules: new techniques in evaluation

What you need to know about Thyroid Cancer

Mandana Moosavi 1 and Stuart Kreisman Background

RESEARCH ARTICLE. Comparison of Presentation and Clinical Outcome between Children and Young Adults with Differentiated Thyroid Cancer

Endocrine, Original Article The Impact of Thyroid Stunning on Radioactive Iodine Ablation Compared to Other Risk Factors

Differentiated Thyroid Carcinoma

Low - dose radioiodine ablation of remnant thyroid in high - risk differentiated thyroid carcinoma

Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist

WTC 2013 Panel Discussion: Minimal disease

Evaluation and Management of Thyroid Nodules. Overview of Thyroid Nodules and Their Management. Thyroid Nodule detection: U/S versus Exam

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study

Hong Kong SAR, China; 2 Department of Surgery, Division of Endocrine Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China

Context: Recent trial results have revived interest in low-activity initial 131 I therapy (RIT) of differentiated thyroid cancer (DTC).

An Unexpected Cause of Hypoglycemia

Key Words. Thyroid cancer Age Prognostic indicators Cancer stage

2.3. THYROID STUNNING ROBERT J. AMDUR, MD AND ERNEST L. MAZZAFERRI, MD, MACP

MOST PATIENTS WITH differentiated thyroid cancer

Table 1: Thyroid panel. Result (reference interval) TSH 89.5 miu/l ( ) Total T4 5.2 µg/dl ( ) T3 uptake 39% (22-35)

THERAPEUTIC DOSES OF radioactive iodine ( 131 I; RAI)

International Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer

2748 jcem.endojournals.org J Clin Endocrinol Metab, August 2012, 97(8):

Follow-up of patients with thyroglobulinantibodies: Rising Tg-Ab trend is a risk factor for recurrence of differentiated thyroid cancer

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

Original Article. Maria Cristina Magracia Jauculan, Myrna Buenaluz-Sedurante, Cecilia Alegado Jimeno

Case 5: Thyroid cancer in 42 yr-old woman with Graves disease

Pediatric Thyroid Cancer Lung Metastases. Liora Lazar MD

Long-term follow-up of patients with benign thyroid nodules

THYROID FUNCTION TEST and RADIONUCLIDE THERAPY

(Not so) New Guidelines for Management of Thyroid Nodules and Differentiated Thyroid Cancer Minnesota/Midwest Chapter of AACE

34 year-old Female with Thyroid Cancer

Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study

Journal of Nuclear Medicine, published on August 14, 2008 as doi: /jnumed

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine

Towards a selective use of postoperative radioiodine in thyroid cancer patients

Distant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination

Papillary Thyroid Carcinoma Presented with Huge Bone Metastases Right Ileum and Frontal Bones

Transcription:

Thyroid Cancer & rhtsh: When and How? 8 th Postgraduate Course in Endocrine Surgery Capsis Beach, Crete, September 21, 2006 Quan-Yang Duh, Professor of Surgery, UCSF

Increasing Incidence of Thyroid Cancer 24, 200 new cases of thyroid cancer in 2004 1,500 died of thyroid cancer in 2004 290,000 survivors of thyroid cancer in USA The incidence doubled from 1990 4% increase per year (2004, SEER)

Paradigm Shift in Management and Follow up of Papillary Thyroid Cancer most patients who eventually achieved freedom from disease do so by surgery with fewer patients cured by repetitive radioiodine treatments. Kloos RT.: Curr Treat Options Oncol. 2005 Jul;6(4):323-38.

Management of Differentiated Thyroid Cancer at UCSF Total thyroidectomy, except small incidental tumor Preop ultrasound. No nerve monitoring. Selective node dissection, large or palpable nodes Re-resection for large or palpable recurrences RAI ablation & therapy (thyroxin w/d or rhtsh-stim) Thyroid hormone to suppress TSH Follow up: US and rhtsh-stim Tg & RAI Rarely external radiation and chemotherapy in advance disease for palliation Experimental re-differentiation therapy

Post-Thyroidectomy Surveillance for Persistent or Recurrent Cancer (UCSF) Total thyroidectomy Hormone-withdrawal RAI scan and treatment Optional rhtsh-stimulated RAI scan and treatment Initial 6-month then yearly rhtsh-stimulated Tg & RAI scan, and neck ultrasound Less frequently after several years Are all three tests necessary? PET scan if Tg-positive but RAI-negative Ultrasound guided FNA to confirm neck recurrence

Spitzweg & Morris: Clin Endocrinol 57:559, 2002 TSH Stimulates Iodine Uptake & Thyroglobulin Production

Decrease Iodine Uptake by Thyroid Cancer Spitzweg & Morris: Clin Endocrinol 57:559, 2002

Thyroid-Hormone-Withdrawal Protocol for Initial RAI-Tx after Thyroidectomy (UCSF) Levothyroxine (T4) for 4-6 weeks Cytomel (T3) for 2-3 week Stop T3 for 1-2 weeks, on low iodine diet (< 50 mcg/d) until serum TSH level > 30 mu/l 4 mci (148 MBq) diagnostic scan (Dx-WBS) 30-50 mci for ablation or 100-200 mci for treatment followed by post-tx-wbs

Recombinant Human TSH-Stimulation Protocol for Follow up after Thyroidectomy (UCSF) Pre-study Low iodine diet (< 50 microgram/d) for 1 week Continue levothyroxine (T4) therapy Day 1 Blood for serum levels of Tg and TSH Urine pregnancy test if indicated rhtsh 0.9 mg IM first dose Day 2 rhtsh 0.9 mg IM second dose

Recombinant Human TSH-stimulation Protocol for Follow up after Thyroidectomy (UCSF) Day 3 131 I 4 mci PO Day 5 Blood for serum Tg Neck and whole-body scan Positive study: Tg > 2 ng/ml or + RAI scan indicate persistent or recurrent disease

Recombinant Human TSH-Stimulation Protocol for Follow up after Thyroidectomy (UCSF) Low iodine diet rhtsh 0.9 mg rhtsh 0.9 mg 131 I 4 mci Scan -7 1 2 3 4 5 Day Check Tg, preg.,tsh Levothyroxine Tg. Tg.

Recombinant Human TSH (rhtsh) Thyrogen (thyrotropin alfa for injection) Modified Chinese hamster ovary cell line Human alpha 92 aa, beta 118 aa, glycosylated, slialylated not sulfated 1.1 mg (4-12 IU/L) dissolved in 1.2 ml water, IM 1 cc gives 0.9 mg

Can high level of TSH be achieved? Standard regiment achieves high serum levels of TSH Kohlfuerst S, Igerc I, Lind P. Thyroid. 2005 Apr;15(4):371-6.

rhtsh Compared with Thyroid Hormone Withdrawal rhtsh is safe rhtsh-tg similar to THW-Tg rhtsh-wbs similar to THW-WBS 10-15% discordance Woodmansee WW, Haugen BR. Clin Endocrinol (Oxf). 2004 Aug;61(2):163-73.

Woodmansee WW, Haugen BR. Clin Endocrinol (Oxf). 2004 Aug;61(2):163-73. Similar Diagnostic Accuracy (RAI-WBS & Stim-Tg) rhtsh vs. T4 Withdrawal

Is rhtsh cost effective? Cost-utility decision-analysis Used the 6 comparative studies of rhtsh versus thyroid hormone withdrawal 11% discordance between studies $51,344 per QALY over a five year when use rhtsh compared to thyroxin-withdrawal Blamey S, Barraclough B, Delbridge L, Mernagh P, Standfield L, Westo ANZ J Surg. 2005 Jan-Feb;75(1-2):10-20.

rh-tsh-stimulated Tg Predicts Persistent or Recurrent Differentiated Thyroid Cancer Tg pers.rec/n % <0.5 ng/ml 1/68 1.6% 0.5-2 ng/ml* 1/19 5% >2 ng/ml 16/20 80% (*50% became <0.5 ng/ml on f/u)kloos RT, Mazzaferri EL.: JCEM 2005 <0.9 ng/ml 1/70 1.4% 0.9-5 ng/ml 2/7 29% >5 ng/ml 22/27 81% David A, et al: Thyroid. 2005;15(3):267-73.

How to interpret rhtsh-stimulated Tg level? Undetectable Thyroglobulin very little risk for recurrence (1-2%) Detectable but low Thyroglobulin Some become undetectable over time 5-30% have pers/rec disease depending on the threshold (2 or 5 ng/ml) Elevated Thyroglobulin 80% pers/rec disease

Add Ultrasound Postoperative surveillance of cervical recurrence by ultrasonography: Improves sensitivity Replaces RAI scan in low risk patients

TSH-stimulated Tg and Ultrasound are Sensitive in Detecting Persistent or Recurrent Disease Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D J Clin Endocrinol Metab. 2004 Jul;89(7):3402-7.

Off Label Use rhtsh-stimulated PET scan rhtsh-stimulated radioiodine ablation of thyroid remnant after thyroidectomy rhtsh-stimulated radioiodine treatment for thyroid cancer rhtsh-stimulated radioiodine treatment for multinodular goiter

rhtsh-stimulated Radioiodine Remnant Ablation or Treatment Indications High risk from hypothyroidism Insufficient TSH response from withdrawal Patient preference Difference from withdrawal No symptoms of hypothyroidism RAI clearance is faster Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, Pacini F. Endocr Relat Cancer. 2005 Mar;12(1):49-64.

rhtsh-stimulated Radioiodine Remnant Ablation or Treatment Review of 400 patients from 30 centers 65% of 115 late stage patients benefited 2% complete remission 36% partial response 27% disease stabilization Tumor expansion and compression causing neurological or respiratory problem Pretreatment with glucocorticoid needed in some Less or more risk than thyroid hormone withdrawal? Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, Pacini F. Endocr Relat Cancer. 2005 Mar;12(1):49-64.

100 mci RAI uptake same 8 months post tx Tg levels same 8 months post tx

longer half-life less blood dose 100 mci

Short Form (SF)-36

rhtsh-stimulated Radioiodine Used 100 mci 8 months post treatment Same Radioiodine uptake Same thyroglobulin level Longer effective half-life of RAI in remnant 68 h for rh-tsh vs 48 h for withdrawal Lower blood dose of radiation 0.11 for rh-ths vs 0.17 for withdrawal Better quality of life (SF-36) J Clin Endocrinol Metab 2006 91: 926-932 Remnant Ablation vs Thyroid Hormone Withdrawal: Randomized Study

ATA guideline Thyroid, 2006 6-12 months after remnant ablation Ultrasound neck Surgery if US + rhtsh or THW if Tg + or scan + CT (w/o contr) I131 tx US rhtsh

rhtsh for Thyroid Cancer: Summary rhtsh is replacing thyroid hormone withdrawal for surveillance (RAI-Dx & Tg) for recurrence after thyroidectomy for differentiated thyroid cancer. rhtsh may replace thyroid hormone withdrawal for thyroid remnant ablation and RAI-Tx (currently off-label use).

Thank You